S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
AI healthcare stock poised for 36,996% growth? (Ad)
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
1970’s computer coder issues shocking A.I. warning (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Bear Market Funds to Watch This Year
How Biden has already won 2024 (Ad)
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
AI healthcare stock poised for 36,996% growth? (Ad)
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
1970’s computer coder issues shocking A.I. warning (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Bear Market Funds to Watch This Year
How Biden has already won 2024 (Ad)
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
AI healthcare stock poised for 36,996% growth? (Ad)
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
1970’s computer coder issues shocking A.I. warning (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Bear Market Funds to Watch This Year
How Biden has already won 2024 (Ad)
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
AI healthcare stock poised for 36,996% growth? (Ad)
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
1970’s computer coder issues shocking A.I. warning (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Bear Market Funds to Watch This Year
How Biden has already won 2024 (Ad)
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities
Free Trial
NASDAQ:CEMI

Chembio Diagnostics (CEMI) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)
Free CEMI Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$0.45
▼
$0.46
50-Day Range
$0.33
▼
$0.46
52-Week Range
$0.19
▼
$1.24
Volume
351,642 shs
Average Volume
661,416 shs
Market Capitalization
$16.71 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
CEMI stock logo

About Chembio Diagnostics Stock (NASDAQ:CEMI)

Chembio Diagnostics, Inc. engages in the developing, manufacturing, marketing, and licensing of rapid medical tests. It offers rapid point-of-care tests for infectious, tropical and fever, and respiratory diseases, handheld analyzers, and veterinary products. The firm distributes its products to hospitals and clinics, physician offices, clinical laboratories, public health organizations, government agencies, and consumers. The company was founded in 1985 and is headquartered in Medford, NY.

CEMI Stock News Headlines

April 17, 2024 | finance.yahoo.com
ANY LAB TEST NOW Forms Strategic Partnership with Chembio
November 2, 2023 | morningstar.com
Quest Diagnostics Inc DGX
April 19, 2024 | Gold Safe Exchange (Ad)
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
July 24, 2023 | marketwatch.com
Qualigen Therapeutics Sells FastPack Diagnostics Business to Chembio
April 27, 2023 | finance.yahoo.com
Biosynex Completes Acquisition of Chembio Diagnostics, Inc.
April 27, 2023 | markets.businessinsider.com
Analysts Have Conflicting Sentiments on These Healthcare Companies: Laboratory (LH), Arbutus Biopharma (ABUS) and Chembio Diagnostics (CEMI)
April 20, 2023 | benzinga.com
Shareholder Alert: Ademi LLP investigates whether Chembio Diagnostics, Inc. has obtained a Fair Price in its transaction with Biosynex
April 19, 2023 | finance.yahoo.com
Chembio Stockholders Urged to Tender Shares Before 6:00 P.M., New York City Time, on April 26, 2023
April 19, 2024 | Gold Safe Exchange (Ad)
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
April 14, 2023 | msn.com
Chembio Diagnostics And 2 Other Stocks Under $1 Insiders Are Aggressively Buying
April 10, 2023 | finance.yahoo.com
Chembio Stockholders Reminded to Tender Shares Before 6:00 P.M., New York City Time, on April 12, 2023
April 3, 2023 | finance.yahoo.com
Chembio’s CEO Letter to Stockholders
March 21, 2023 | finance.yahoo.com
Chembio Stockholders Reminded to Tender Shares Before 6:00 PM New York City Time, on March 28, 2023
March 15, 2023 | finance.yahoo.com
Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc.
March 15, 2023 | finance.yahoo.com
Chembio Announces Letter to Stockholders Regarding Tender Offer
February 24, 2023 | finance.yahoo.com
Chembio Announces the Receipt of CLIA Waiver for its DPP HIV-Syphilis System
February 8, 2023 | benzinga.com
Moore Kuehn Encourages ALBO, LPTX, ALR, and CEMI Investors to Contact Law Firm
February 2, 2023 | wsj.com
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Chembio Diagnostics, Inc. Buyout
February 1, 2023 | finance.yahoo.com
French Rapid Testing Company Scoops Up Chembio Diagnostics For $17M
January 31, 2023 | finance.yahoo.com
Biosynex and Chembio Diagnostics Announce Definitive Acquisition Agreement
January 21, 2023 | seekingalpha.com
CEMI Chembio Diagnostics, Inc.
January 7, 2023 | forbes.com
Chembio Diagnostics
November 28, 2022 | finance.yahoo.com
Chembio Announces FDA CLIA Waiver Submission for DPP HIV-Syphilis System
November 6, 2022 | seekingalpha.com
Chembio Diagnostics, Inc. (CEMI) Q3 2022 Earnings Call Transcript
November 3, 2022 | finance.yahoo.com
Chembio Diagnostics Reports Third Quarter 2022 Financial Results
October 20, 2022 | finance.yahoo.com
Chembio Diagnostics to Report Third Quarter 2022 Financial Results on November 3, 2022
September 6, 2022 | finance.yahoo.com
Chembio Diagnostics Awarded $3.2 Million Contract from the CDC for Development and Clinical Validation of Dual-Path Platform Syphilis Screen & Confirm Assay
See More Headlines
Receive CEMI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chembio Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/04/2021
Today
4/19/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:CEMI
CUSIP
N/A
CIK
1092662
Web
www.chembio.com
Phone
(631) 924-1135
Fax
631-924-2065
Employees
337
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($1.20)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-23,290,000.00
Net Margins
-47.03%
Pretax Margin
-46.96%
Return on Equity
-113.57%
Return on Assets
-38.22%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.23
Quick Ratio
1.04

Sales & Book Value

Annual Sales
$48.34 million
Price / Sales
0.35
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.48 per share
Price / Book
0.95

Miscellaneous

Outstanding Shares
36,726,000
Free Float
35,514,000
Market Cap
$16.71 million
Optionable
Not Optionable
Beta
1.85
Investing Strategies To Help Grow Your Retirement Income Cover
Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Richard L. Eberly
    President, Chief Executive Officer & Director
  • Paul J. Angelico
    Chief Operations Officer & Executive VP
  • Lawrence J. Steenvoorden
    Chief Financial Officer, Secretary & Executive VP
  • Javan Esfandiari
    Executive VP, Chief Science & Technology Officer
  • Atif Rizvi
    Vice President-Finance

Key Competitors

View All Competitors

Insiders


CEMI Stock Analysis - Frequently Asked Questions

How were Chembio Diagnostics' earnings last quarter?

Chembio Diagnostics, Inc. (NASDAQ:CEMI) released its quarterly earnings results on Thursday, November, 4th. The company reported ($0.24) EPS for the quarter, missing analysts' consensus estimates of ($0.19) by $0.05. The business had revenue of $12.06 million for the quarter. Chembio Diagnostics had a negative net margin of 47.03% and a negative trailing twelve-month return on equity of 113.57%. During the same period last year, the firm earned ($0.28) earnings per share.

What other stocks do shareholders of Chembio Diagnostics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Chembio Diagnostics investors own include Prospect Capital (PSEC), Calumet Specialty Products Partners (CLMT), Two Harbors Investment (TWO), BlackRock Capital Investment (BKCC), NovoCure (NVCR), Viper Energy (VNOM), Summit Midstream Partners (SMLP), Washington Prime Group (WPG), Roper Technologies (ROP) and ReWalk Robotics (RWLK).

This page (NASDAQ:CEMI) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
The “Perfect Storm” for Gold
Gold Safe Exchange
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press
He Is Giving Away Bitcoin
Crypto Swap Profits
The #1 Crypto for 2024
InvestorPlace
Urgent alert: open this for a huge profit potential
Timothy Sykes
How Biden has already won 2024
Porter & Company